INSM INSMED Inc
P/E
--
Forward P/E
97.09
Price/Sales
18.36
Beta
0.824
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Insmed's first quarter 2026 revenue of $306M crushes estimates, driven by a strong BRINSUPRI launch.
Insmed reported first quarter 2026 revenue of $306.0 million and a net loss of $0.76 per share, significantly beating analyst expectations on both the top and...
Insmed Inc Q1 2026 Earnings Preview: What Analysts Expect on May 07, 2026
For the first quarter of 2026, analysts anticipate Insmed to report consensus revenue of $114.8 million and an EPS loss of -$0.92, with the current stock price...